Ottmann OG - Search Results

1

Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL.

Topp MS, Gökbuget N, Zugmaier G, Degenhard E, Goebeler ME, Klinger M, Neumann SA, Horst HA, Raff T, Viardot A, Stelljes M, Schaich M, Köhne-Volland R, Brüggemann M, Ottmann OG, Burmeister T, Baeuerle PA, Nagorsen D, Schmidt M, Einsele H, Riethmüller G, Kneba M, Hoelzer D, Kufer P, Bargou RC. Topp MS, et al. Among authors: ottmann og. Blood. 2012 Dec 20;120(26):5185-7. doi: 10.1182/blood-2012-07-441030. Epub 2012 Sep 28. Blood. 2012. PMID: 23024237 Free article. Clinical Trial.

2

Acute lymphoblastic leukemia with the (4;11) translocation: combined cytogenetic, immunological and molecular genetic analyses.

Schardt C, Ottmann OG, Hoelzer D, Ganser A. Schardt C, et al. Among authors: ottmann og. Leukemia. 1992 May;6(5):370-4. Leukemia. 1992. PMID: 1375695

3

In vitro culture of common acute lymphoblastic leukemia blasts: effects of interleukin-3, interleukin-7, and accessory cells.

Eder M, Ottmann OG, Hansen-Hagge TE, Bartram CR, Falk S, Gillis S, Hoelzer D, Ganser A. Eder M, et al. Among authors: ottmann og. Blood. 1992 Jun 15;79(12):3274-84. Blood. 1992. PMID: 1596568 Free article.

4

Effects of recombinant human interleukin-3 on human hematopoietic progenitor and precursor cells in vivo.

Ottmann OG, Ganser A, Seipelt G, Eder M, Schulz G, Hoelzer D. Ottmann OG, et al. Blood. 1990 Oct 15;76(8):1494-502. Blood. 1990. PMID: 2207325 Free article. Clinical Trial.

5

Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase I/II trial.

Ganser A, Völkers B, Greher J, Ottmann OG, Walther F, Becher R, Bergmann L, Schulz G, Hoelzer D. Ganser A, et al. Among authors: ottmann og. Blood. 1989 Jan;73(1):31-7. Blood. 1989. PMID: 2642714 Free article.

6

Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: a randomized phase III trial.

Ottmann OG, Hoelzer D, Gracien E, Ganser A, Kelly K, Reutzel R, Lipp T, Busch FW, Schwonzen M, Heil G, et al. Ottmann OG, et al. Blood. 1995 Jul 15;86(2):444-50. Blood. 1995. PMID: 7541660 Free article. Clinical Trial.

7

Simultaneous administration of granulocyte colony-stimulating factor (Filgrastim) and induction chemotherapy in acute lymphoblastic leukemia. A pilot study.

Ottmann OG, Ganser A, Freund M, Heil G, Hiddemann W, Heit W, Gracien E, Hoelzer D. Ottmann OG, et al. Ann Hematol. 1993 Oct;67(4):161-7. doi: 10.1007/BF01695862. Ann Hematol. 1993. PMID: 7692982 Clinical Trial.

8

Interleukin 3 and interleukin 3/GM-CSF combination therapy--clinical implications.

Ganser A, Ottmann OG, Hoelzer D. Ganser A, et al. Among authors: ottmann og. Stem Cells. 1993 Nov;11(6):465-73. doi: 10.1002/stem.5530110616. Stem Cells. 1993. PMID: 8111306 Review. No abstract available.

9

Do G-CSF and GM-CSF contribute to the management of acute lymphoblastic leukemia?

Ottmann OG, Hoelzer D. Ottmann OG, et al. Leukemia. 1996 Jul;10(7):1111-6. Leukemia. 1996. PMID: 8683988 Review. No abstract available.

10

[Clinical administration of hematopoietic growth factors. When and where?].

Ottmann OG, Seipelt G, Hoelzer D. Ottmann OG, et al. Internist (Berl). 1997 Dec;38(12):1160-7. doi: 10.1007/s001080050128. Internist (Berl). 1997. PMID: 9465321 Review. German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

305 results

Search Page